Table 2 Correlation of GD2 expression to clinicopathologic factors of Chinese melanoma patients
Clinico pathologic feature | GD2+ (%) | GD2− (%) | P valuea |
|---|---|---|---|
Age (year) | |||
 Median (range) | 52.7 ± 13.5 | 51.1 ± 15.2 | 0.348 |
Gender n (%) | |||
 Male | 69 (48.6) | 74 (50.7) | 0.722 |
 Female | 73 (51.4) | 72 (49.3) | |
Ulceration n (%) | |||
 Yes | 82 (57.7) | 84 (57.5) | 0.971 |
 No | 60 (42.3) | 62 (42.5) | |
Thickness | |||
 Median (range) | 3.5 (0.5,20.0) | 3.7 (0.5,19.5) | 0.581 |
TNM stage n (%) | |||
 I (16) | 5 (3.5) | 11 (7.5) | 0.003 |
 II (109) | 41 (28.9) | 68 (46.6) | |
 III (92) | 55 (38.7) | 37 (25.3) | |
 IV (71) | 41 (28.9) | 30 (20.5) | |
Metastasis | |||
 Yes | 96 (67.6) | 67 (45.9) | < 0.0001 |
 No | 46 (32.4) | 79 (54.1) | |
Primary site | |||
 Acral (134) | 67 (47.2) | 67 (45.9) | 0.017 |
 Mucosal (71) | 40 (28.2) | 31 (21.2) | |
 CSD (14) | 2 (1.4) | 12 (8.2) | |
 Non-CSD (27) | 9 (6.3) | 18 (12.3) | |
 Unknown primary (42) | 24 (16.9) | 18 (12.3) | |
Survival (months) | |||
 Median (95% CI) | 31 (34.1,60.1) | 47.1 (21.3,40.7) | < 0.0001 |